| Novartis Pharma Schweiz AG - Exelon 3 mg, Kapseln |
| 54275 | | 04 | | Exelon 3 mg | | Kapseln | | N06DA03 | | Rivastigmine | | 31.07.1997 | | |
|
| Composition |
| rivastigminum 3 mg ut rivastigmini hydrogenotartras, silica colloidalis anhydrica, hypromellosum, magnesii stearas, cellulosum microcristallinum, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (rubrum), pro capsula. |
| Packungsbestandteile |
| Capsules | | | | | Active Agent | Dose |
|---|
| Rivastigmine | 3 mg |
| | BAG: Active Agent | Dose |
|---|
| Rivastigmine | 3 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Hypromellosum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Pro Capsula | | | | Silica Colloidalis Anhydrica | | |
| |
|
| Teilbarkeit |
| | Nein | | | | kA | | | | kA | | | | kA | | | | Vorschlag: Exelon Lösung verwenden | | | | | |
|
|
